Answers are grounded in this paper and cite their sources.
The elderly patient with advanced cancer frequently suffers from a multiplicity of symptoms and comorbidities. These, in combination with the physiological effects of ageing, predispose such patients to adverse effects of drugs frequently used in palliative care. An understanding of the altered pharmacokinetic and side effect profiles of these drugs in the elderly is required to optimise patient management. The application of these principles to selected drugs is discussed.
No takes yet. Share an insight, caveat, or question.
Tim C Lightfoot (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: